Biotech News
Related news
IRIXIRIDEX2026-08-18 20:05 EST
Iridex Reports Second Quarter 2026 Financial Results
ANGOAngioDynamics2026-10-08 10:02 EST
AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability
HYPRHyperfine2026-10-08 11:30 EST
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026
IARTIntegra LifeSciences2026-10-06 12:30 EST
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026
MGTXMeiraGTx2026-08-13 12:00 EST
MeiraGTx Reports Second Quarter 2026 Financial and Operational Results
XAIRBeyond Air2026-08-13 11:00 EST
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
BLTEBelite Bio2026-08-13 01:45 EST
Belite Bio Reports Unaudited Second Quarter 2026 Financial Results and Provides a Corporate Update
STIMNeuronetics2026-08-11 11:50 EST
Neuronetics Reports Second Quarter 2026 Financial and Operating Results
TCMDTactile Systems Technology, Inc.2026-08-10 20:05 EST
Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results
TMCITreace Medical Concepts2026-08-07 11:05 EST
Treace Medical Concepts Reports Second Quarter 2026 Financial Results
IRIDEX
Ophthalmic Laser Technology Company Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology. Its products are used by eye-care specialists to treat glaucoma, diabetic macular edema, and other retinal diseases. MicroPulse Technology The company's proprietary MicroPulse...
Recent company news
IRIXIRIDEX2026-10-05 11:00 EST
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
IRIXIRIDEX2026-08-18 20:05 EST
Iridex Reports Second Quarter 2026 Financial Results
IRIXIRIDEX2026-08-04 20:05 EST
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
IRIXIRIDEX2026-07-20 11:00 EST
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
IRIXIRIDEX2026-06-09 20:05 EST
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
Stock data
- Close
- 0.68 USD
- Market cap
- 20.37M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States